Reticulated platelets and antiplatelet therapy response in diabetic patients

Journal of Thrombosis and Thrombolysis

Volumn 40, Issue 2, 2015, Pages 203-210

  Mijovic, Romana ^a,c   Kovacevic, Nada ^b   Zarkov, Marija ^a,c   Stosic, Zoran ^a,c   Cabarkapa, Velibor ^a,c   Mitic, Gorana ^a,c  

^a CLINICAL CENTER OF VOJVODINA   (Serbia)

^b Health Center   (Serbia)

^c UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Antiplatelet therapy; Clopidogrel; Diabetes mellitus type 2; Reticulated platelets

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CLOPIDOGREL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; TICLOPIDINE;

ADULT; ARTICLE; BODY MASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DRUG RESPONSE; FEMALE; HOMEOSTASIS MODEL ASSESSMENT ESTIMATED INSULIN RESISTANCE INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETICULATED PLATELET; SERBIA; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE METABOLISM; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGED; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; METABOLISM; MIDDLE AGED;

ADULT; AGED; BLOOD PLATELETS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 84934915879     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-014-1165-3     Document Type: Article

References (18)

1. Ferreiro JL, Gomez-Hospital JA, Angiolillo DJ (2009) Platelet abnormalities in diabetes mellitus. Diabetes Vasc Dis Res 7(4):251–259
2. Angiolillo DJ, Shoemaker SB, Desai B et al (2007) Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the optimizing antiplatelet therapy in diabetes mellitus (OPTIMUS) study. Circulation 115:708–716
3. Gurbel PA, Tantry US (2007) Clopidogrel resistance? Thromb Res 120:311–321
4. Vlachojannis GJ, Dimitropoulos G, Alexopoulos D (2011) Clopidogrel resistance: current aspects and future directions. Hellenic J Cardiol 52:236–245
5. Kakouros N, Rade JJ, Kourliouros A, Resar JR (2011) Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol. doi:10.1155/2011/742719
6. Ferreiro JL, Angiolillo DJ (2011) Diabetes and antiplatelet therapy in acute coronary syndrome. Circulation 123:798–813
7. Giusti B, Gori AM, Marcucci R, Saracini C, Vestrini A, Abbate R (2010) Determination to optimize response to clopidogrel in acute coronary syndrome. Pharmacogenomics Pers Med 3:33–50
8. Angiolillo DJ, Ferreiro JL (2010) Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions. Rev Esp Cardiol 63(1):60–76
9. Ibrahim H, Nadipalli S, DeLao T, Guthikonda S, Kleiman NS (2012) Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness. J Thromb Thrombolysis 33:137–142
10. Guthikonda S, Lev EI, Patel R et al (2007) Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 5:490–496
11. Guthikonda S, Alviar CL, Vaduganathan M et al (2008) Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. JACC 52(9):743–749
12. Hoffmann JJ (2014) Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med 52(8):1107–1117
13. Hoffman JJ, van den Broek NM, Curvers J (2013) Reference intervals of reticulated platelets and other platelet parameters and their associations. Arch Pathol Lab Med 137:1635–1640
14. Wurtz M, Wulff LN, Grove EL, Kristensen SD et al (2012) Influence of renal function and platelet turnover on the antiplatelet effect of aspirin. Thromb Res 129:434–440
15. Larsen SB, Grove EL, Hvas A-M, Kristensen SD (2014) Platelet turnover in stable coronary artery disease—Influence of thrombopoietin and low-grade inflammation. PLoS One 9(1):e85566. doi:10.1371/journal.pone.0085566
16. Lee EY, Kim SJ, Song YJ, Choi SJ, Song J (2013) Immature platelet fraction in diabetes mellitus and metabolic syndrome. Thromb Res 132:692–695
17. Gremmel T, Kopp CW, Seidinger D et al (2013) Impact of diabetes on platelet activation in different manifestations of atherosclerosis. Swiss Med Wkly 143:w13800
18. Vaduganathan M, Alviar CL, Arikan ME (2008) Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. Am Heart J 156(5):1002-e1